|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Production|
|Study Start Date:||2010-10-27|
|Study Made Public:||2011-11-15|
Weiss Forsman Llama study
CAVD 329 is a continuation of CAVD 289. Both studies isolated llama VHH antibody fragments from llamas immunized with HIV-1 ENV proteins. The VHH were selected for targeting the CD4 binding site.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No non-integrated data is available for this study.